HKD27.00
1.50% today
Hong Kong, Nov 26, 09:08 am CET
ISIN
KYG5074A1004
Symbol
6618
Index

JD Health International Target price 2024 - Analyst rating & recommendation

JD Health International Classifications & Recommendation:

Buy
82%
Hold
6%
Sell
12%

JD Health International Price Target

Target Price HKD34.31
Price HKD27.00
Potential
Number of Estimates 14
14 Analysts have issued a price target JD Health International 2025 . The average JD Health International target price is HKD34.31. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 17 analysts: 14 Analysts recommend JD Health International to buy, 1 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the JD Health International stock has an average upside potential 2025 of . Most analysts recommend the JD Health International stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Revenue Billion HKD 59.15 62.01
8.84% 4.84%
EBITDA Margin 1.60% 3.17%
16,955.58% 97.70%
Net Margin 4.10% 5.75%
398.79% 40.31%

15 Analysts have issued a sales forecast JD Health International 2024 . The average JD Health International sales estimate is

HKD62.0b
Unlock
. This is
4.65% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HKD62.9b 6.20%
Unlock
, the lowest is
HKD61.4b 3.59%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 HKD59.2b 8.84%
2024
HKD62.0b 4.84%
Unlock
2025
HKD69.4b 11.98%
Unlock
2026
HKD77.0b 10.85%
Unlock

8 Analysts have issued an JD Health International EBITDA forecast 2024. The average JD Health International EBITDA estimate is

HKD2.0b
Unlock
. This is
79.92% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
HKD2.6b 137.04%
Unlock
, the lowest is
HKD1.5b 35.87%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 HKD948m 18,444.87%
2024
HKD2.0b 107.58%
Unlock
2025
HKD2.7b 39.64%
Unlock
2026
HKD3.3b 21.74%
Unlock

EBITDA Margin

2023 1.60% 16,955.58%
2024
3.17% 97.70%
Unlock
2025
3.96% 24.92%
Unlock
2026
4.35% 9.85%
Unlock

7 JD Health International Analysts have issued a net profit forecast 2024. The average JD Health International net profit estimate is

HKD3.6b
Unlock
. This is
24.31% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HKD3.7b 30.52%
Unlock
, the lowest is
HKD3.4b 17.38%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 HKD2.4b 442.86%
2024
HKD3.6b 47.21%
Unlock
2025
HKD4.1b 15.75%
Unlock
2026
HKD4.5b 9.12%
Unlock

Net Margin

2023 4.10% 398.79%
2024
5.75% 40.31%
Unlock
2025
5.95% 3.48%
Unlock
2026
5.86% 1.51%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share HKD 0.76 1.12
442.86% 47.37%
P/E 23.78
EV/Sales 0.55

7 Analysts have issued a JD Health International forecast for earnings per share. The average JD Health International <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

HKD1.12
Unlock
. This is
24.44% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
HKD1.17 30.00%
Unlock
, the lowest is
HKD1.06 17.78%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 HKD0.76 442.86%
2024
HKD1.12 47.37%
Unlock
2025
HKD1.29 15.18%
Unlock
2026
HKD1.41 9.30%
Unlock

P/E ratio

Current 29.57 53.04%
2024
23.78 19.58%
Unlock
2025
20.54 13.62%
Unlock
2026
18.82 8.37%
Unlock

Based on analysts' sales estimates for 2024, the JD Health International stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.57 51.69%
2024
0.55 4.33%
Unlock
2025
0.49 10.69%
Unlock
2026
0.44 9.79%
Unlock

P/S ratio

Current 1.44 30.61%
2024
1.37 4.44%
Unlock
2025
1.23 10.69%
Unlock
2026
1.11 9.79%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today